PubRank

Mark Puder

Author PubWeight™ 94.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009 4.69
2 A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr 2012 3.42
3 Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 2003 2.07
4 Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008 2.02
5 APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development. Dev Biol 2008 1.90
6 Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 2004 1.70
7 Pediatric anorectal impalement with bladder rupture: case report and review of the literature. J Pediatr Surg 2006 1.69
8 Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr 2012 1.64
9 Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006 1.60
10 The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia. Nutr Clin Pract 2007 1.52
11 Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J 2006 1.52
12 A.S.P.E.N. Clinical Guidelines: hyperglycemia and hypoglycemia in the neonate receiving parenteral nutrition. JPEN J Parenter Enteral Nutr 2011 1.41
13 Newborn and toddler intestinal obstruction owing to congenital mesenteric defects. J Pediatr Surg 2008 1.38
14 Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005 1.37
15 Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg 2003 1.34
16 Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005 1.33
17 Microdeformational wound therapy: effects on angiogenesis and matrix metalloproteinases in chronic wounds of 3 debilitated patients. Ann Plast Surg 2006 1.30
18 Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr 2009 1.25
19 Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant 2010 1.18
20 Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism 2010 1.15
21 Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract 2006 1.10
22 Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 2005 1.10
23 The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2009 1.08
24 Epoxyeicosanoids promote organ and tissue regeneration. Proc Natl Acad Sci U S A 2013 1.08
25 Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acids. Aging Cell 2012 1.04
26 Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr 2011 1.04
27 Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model. Endocrinology 2007 1.02
28 Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg 2011 0.98
29 Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol 2006 0.97
30 Vascular endothelial growth factor accelerates compensatory lung growth after unilateral pneumonectomy. Am J Physiol Lung Cell Mol Physiol 2006 0.96
31 Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation 2005 0.96
32 Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice. PLoS One 2010 0.96
33 Endothelial progenitor cells contribute to accelerated liver regeneration. J Pediatr Surg 2007 0.93
34 The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg 2005 0.93
35 Pneumonectomy in the mouse: technique and perioperative management. J Invest Surg 2005 0.92
36 Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg 2005 0.92
37 The prevention and treatment of intestinal failure-associated liver disease in neonates and children. Surg Clin North Am 2011 0.91
38 Omega-3 fatty acids and liver disease. Hepatology 2007 0.91
39 Sunitinib inhibits postoperative adhesions in a rabbit model. Surgery 2011 0.90
40 Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators. Am J Physiol Gastrointest Liver Physiol 2013 0.88
41 Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg 2010 0.88
42 Effects of metalloproteinase inhibition in a murine model of renal ischemia-reperfusion injury. Pediatr Res 2010 0.88
43 Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. Metabolism 2008 0.88
44 Pediatric rib lesions: a 13-year experience. J Pediatr Surg 2008 0.87
45 Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids. J Pediatr Surg 2008 0.87
46 A critical role for matrix metalloproteinases in liver regeneration. J Surg Res 2008 0.87
47 Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010 0.87
48 Innovative parenteral and enteral nutrition therapy for intestinal failure. Semin Pediatr Surg 2010 0.86
49 Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiol Behav 2010 0.86
50 Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr 2010 0.86
51 Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions. Adv Nutr 2013 0.86
52 Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo. Proc Natl Acad Sci U S A 2008 0.85
53 Docosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis. JPEN J Parenter Enteral Nutr 2011 0.85
54 Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency. Hepatology 2004 0.84
55 The growing role of eicosanoids in tissue regeneration, repair, and wound healing. Prostaglandins Other Lipid Mediat 2013 0.82
56 Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity. Hepatol Res 2012 0.82
57 A metabolomic analysis of two intravenous lipid emulsions in a murine model. PLoS One 2013 0.82
58 The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model. Metabolism 2012 0.81
59 Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice. PLoS One 2011 0.81
60 The role of the ω-3 fatty acid DHA in the human life cycle. JPEN J Parenter Enteral Nutr 2012 0.81
61 Purified fish oil eliminating linoleic and alpha linolenic acid meets essential fatty acid requirements in rats. Metabolism 2012 0.80
62 Cholestasis and growth in neonates with gastroschisis. J Pediatr Surg 2012 0.80
63 Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease. Curr Opin Pediatr 2013 0.80
64 Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib. Pediatr Res 2011 0.80
65 The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg 2015 0.80
66 Effects of glucose or fat calories in total parenteral nutrition on fat metabolism and systemic inflammation in rats. Metabolism 2010 0.79
67 A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for metabolic bone disease. JPEN J Parenter Enteral Nutr 2013 0.79
68 Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009 0.79
69 Dietary fish oil aggravates paracetamol-induced liver injury in mice. JPEN J Parenter Enteral Nutr 2012 0.78
70 Prenatal diagnosis and subsequent treatment of an intermediate-risk paraspinal neuroblastoma: case report and review of the literature. Fetal Diagn Ther 2008 0.78
71 Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome. Nutr Clin Pract 2010 0.77
72 Inhibition of intra-abdominal adhesion formation with the angiogenesis inhibitor sunitinib. J Surg Res 2007 0.77
73 A tutorial on fatty acid biology. JPEN J Parenter Enteral Nutr 2012 0.77
74 Cardiac relocation and chest wall reconstruction after separation of thoracopagus conjoined twins with a single heart. J Pediatr Surg 2002 0.77
75 Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease. J Pediatr Surg 2011 0.77
76 Urinary matrix metalloproteinases and their endogenous inhibitors predict hepatic regeneration after murine partial hepatectomy. Transplantation 2004 0.77
77 Sunitinib reduces recurrent pelvic adhesions in a rabbit model. J Surg Res 2012 0.77
78 Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury. J Pediatr Surg 2011 0.76
79 Role of parenteral lipid emulsions in the preterm infant. Early Hum Dev 2013 0.76
80 Controlled release of vascular endothelial growth factor enhances intestinal adaptation in rats with extensive small intestinal resection. Surgery 2011 0.76
81 Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet. Prostaglandins Leukot Essent Fatty Acids 2010 0.76
82 Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int 2008 0.76
83 Effect of sunitinib on functional reproductive outcome in a rabbit model. Fertil Steril 2012 0.76
84 Arachidonic acid and docosahexaenoic acid supplemented to an essential fatty acid-deficient diet alters the response to endotoxin in rats. Metabolism 2011 0.76
85 Determining the need for simulated training of invasive procedures. Adv Health Sci Educ Theory Pract 2006 0.75
86 Response to the letter to the editor regarding Nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr 2012 0.75
87 Re: Influence of different intravenous lipid emulsions on hepatobiliary dysfunction in a rabbit model. J Pediatr Gastroenterol Nutr 2008 0.75
88 The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Nutrients 2012 0.75
89 Parenteral nutrition in the critically ill patient. N Engl J Med 2010 0.75
90 Response to Meyer and Gortner. JPEN J Parenter Enteral Nutr 2012 0.75
91 Assessing portal fibrosis in parenteral nutrition-dependent patients treated with omega-3 fatty acid lipid emulsion. J Pediatr 2010 0.75
92 Infant parenteral nutrition-associated cholestasis: a severe iatrogenic disease. JPEN J Parenter Enteral Nutr 2009 0.75
93 Recent developments in aluminium contamination of products used in parenteral nutrition. Curr Opin Clin Nutr Metab Care 2006 0.75
94 A resident's guide to personal finance. Curr Surg 2005 0.75
95 Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis. Pediatr Surg Int 2006 0.75
96 Thymoma in a child: case report and review of the literature. Pediatr Surg Int 2005 0.75
97 Response to Driscoll. JPEN J Parenter Enteral Nutr 2017 0.75